Loading clinical trials...
Loading clinical trials...
A Trial of Favipiravir Therapy in Adults With Mild Coronavirus Disease COVID-19
Conditions
Interventions
Favipiravir
Placebo
Locations
7
Saudi Arabia
King Fahad Hospital - Madinah
Al Madīnah, Saudi Arabia
Primary Health Care-Safiyah
Al Madīnah, Saudi Arabia
Prince Mohammed Bin Abdul Aziz Hospital - Al Madinah
Al Madīnah, Saudi Arabia
King Abdullah Medical City - Makkah
Mecca, Saudi Arabia
King Abdulaziz Medical City - Riyadh
Riyadh, Saudi Arabia
Primary Health Care-Al Mansoura
Riyadh, Saudi Arabia
Start Date
July 23, 2020
Primary Completion Date
August 4, 2021
Completion Date
August 4, 2021
Last Updated
November 5, 2021
NCT06082518
NCT07221162
NCT06631287
NCT06679140
NCT06417762
NCT03830320
Lead Sponsor
King Abdullah International Medical Research Center
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions